Novel Risk Factors and Localization of Peripheral Arterial Disease
Key facts
- Who runs it
- Centre Hospitalier Universitaire de la Guadeloupe
- Where
- Guadeloupe1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 123 people enrolled
- Started
- 4 Apr 2019
- Ended
- 22 Apr 2025
- Type of study
- Observational, 2 groups
- Record updated
- 18 November 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- men or women aged more than 18 years old
- with PAD diagnosed with systolic pressure index (SPI) <0.9 or toe systolic pressure <85 mmHg or tissue oxygen saturation < 65 mmHg or with stenosis >50 % or occlusion of one or more arteries
- Patients with or without diabetes
- with stenosis >50 % or occlusion of one or more arteries, infra popliteal, supra or popliteal
- wishing to take part in the study
- having signed the informed consent
- Patients affiliated or beneficiary of a social security scheme
Who cannot take part
- Patients with an history of revascularization at supra popliteal, popliteal or infra popliteal level AND stenosis on a different territory
- Patients aged less than 18 years old
- Patients who do not wish to participate in the study
- Patients with PAD with localization infra popliteal and supra popliteal or popliteal (stenosis > 50 % or occlusion of an artery at supra popliteal or popliteal level AND infra popliteal level)
- Patients with medial calcific sclerosis without PAD
- PAD from non-atherosclerotic origin
- Patient non-affiliated to the social security scheme
- Pregnant or breastfeeding women
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Background: .Atherosclerotic peripheral arterial disease (PAD) is associated with a high risk of mortality, coronary events and stroke. The distal localization is frequently associated with amputation. Patients from African origin have a higher prevalence of PAD independently of age and other risk factors. In Guadeloupe, French West Indies, infra popliteal localization is more frequent than in France continental associated with different risk factors (88% of hypertension, 2/3 of diabetes).
Read full original descriptionShow less
Purpose: Traditional risk factors of PAD are smoking diabetes, hypertension, high lipid levels, age, and family history of cardiovascular events. The role of novel risk factors in PAD has recently been shown: fibrinogen, CRP-us, homocysteine, interleukin 6, the neutrophil-to-lymphocyte ratio, the urinary albumin-to-creatinine ratio, alkaline phosphatases, insulin resistance, uric acid, D dimer, vitamin D deficiency, HBA1C. Thus the purpose of the research is to study the role of novel risk factors in the occurrence of infrapopliteal PAD. The primary criterion is the HBA1C.
The 2 groups in the trial
- group 1
culprit lesion is infra popliteal
- group 2
culprit lesion is supra or popliteal
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 18 November 2025